InvestorsHub Logo
Followers 4
Posts 129
Boards Moderated 0
Alias Born 05/11/2016

Re: Watsonturtle post# 17308

Thursday, 02/08/2024 5:29:59 PM

Thursday, February 08, 2024 5:29:59 PM

Post# of 17421
Chatter I am seeing is that, based on the new KDIGO guidelines, the relevant US docs treating LN class III and IV are expected to make VOC/Lupkynis part of a new SOC for such LN patients. It might be too early for data, but it would be great if they had some data to show impact of KDIGO 2024 guidelines. WT
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AUPH News